Filing Details

Accession Number:
0000945769-12-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-18 10:38:36
Reporting Period:
2012-07-16
Filing Date:
2012-07-18
Accepted Time:
2012-07-18 10:38:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887497 Hi Tech Pharmacal Co Inc HITK Pharmaceutical Preparations (2834) 112638720
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263136 J William Peters C/O Hi-Tech Pharmacal Co., Inc.
369 Bayview Avenue
Amityville NY 11701
Vp And Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-16 4,983 $19.95 4,983 No 4 M Direct
Common Stock Disposition 2012-07-16 4,983 $32.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-07-16 4,983 $0.00 4,983 $19.95
Common Stock Stock Option (Right to Buy) Acquisiton 2012-07-16 30,000 $0.00 30,000 $32.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-09-08 2013-09-08 No 4 M Direct
30,000 2013-07-16 2022-07-16 No 4 A Direct
Footnotes
  1. The option exercise and open market sale were made pursuant to a 10b5-1 trading plan adopted by the filer in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
  3. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a Rule 16b-3 Plan.
  4. The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
  5. Other than the option to acquire 30,000 shares reflected on this form as acquired by the filer as a result of the option grant, the filer is also the holder of additional options to acquire 123,750 shares of Hi-Tech Common Stock (for aggregate options to acquire a total of 153,750 shares of Common Stock), which options were granted on various dates, with varying exercise prices and exercisable and expiration dates.